A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID)

14Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Objective: While it is well known that patients with common variable immunodeficiency (CVID) are predisposed to various malignancies, primarily non-Hodgkin's lymphoma and gastric carcinomas, to our knowledge no cases of hepatocellular carcinoma have been reported in the absence of preexisting liver disease. Method and Results: We report a 50-year-old male patient with CVID with a B- and T-cell deficiency. The patient was on prophylactic intravenous gammaglobulin and had received several years earlier a course of rituximab for an autoimmune disorder. He had no history of hepatitis. The patient developed a rapidly progressing hepatocellular carcinoma within 3 to 4 weeks. Conclusions: Although patients with CVID are predisposed to malignancies such as lymphoma and adenocarcinoma of the stomach, rapidly progressive hepatocellular carcinoma in the absence of any preexisting liver disease has not been described. © 2010 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Gandhi, K., Parikh, P., Aronow, W. S., Desai, H., Amin, H., Sharma, M., & Rubinstein, A. (2010). A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID). Journal of Gastrointestinal Cancer, 41(4), 281–284. https://doi.org/10.1007/s12029-010-9158-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free